\-\ Texto\\:\\ \ \(0\)\
\-\ physical\\:\\ large\\,\\ hard\\,\\ irregular\\ mass\\ in\\ left\\ testicle\\.\ \(0\)\
\-\ labs\\:\\ afp\\ 3\\ \\(normal\\)\\,\\ bhcg\\ 4\\ \\(normal\\)\\,\\ ldh\\ 352\\ \\(elevated\\)\ \(0\)\
\-\ left\\ testicle\\ was\\ removed\\.\\ \\ radiation\\ rx\\ pending\\.\\ \\ expect\\ yearly\\ sonography\\ to\\ monitor\\ for\\ developement\\ of\\ tumor\\ in\\ right\\ testicle\\.\ \(0\)\
\-\ 1\\.\\ large\\,\\ lobular\\ intratesticular\\ mass\\,\\ 2\\.5\\ cm\\ x\\ 4\\.3\\ cm\\,\\ heterogeneous\\,\\ predominately\\ hypoechoic\\ lesion\\ in\\ left\\ testicle\\.\ \(0\)\
\-\ 2\\.\\ bilateral\\ coarse\\ microlithiasis\\.\ \(0\)\
\-\ testicular\\ microlithiasis\ \(11\)\
\-\ seminoma\\,\\ classic\\ type\ \(0\)\
\-\ ddx\\:\\ mass\ \(0\)\
\-\ 1\\.\\ seminoma\\ \\(classic\\,\\ spermatocytic\\)\\ \ \(0\)\
\-\ 2\\.\\ nonseminomatous\\ germ\\ cell\\ tumor\\ \\(mixed\\ malignant\\ germ\\ cell\\,\\ embryonal\\ cell\\ carcinoma\\,\\ yolk\\ sac\\,\\ teratoma\\,\\ choriocarcinoma\\)\ \(0\)\
\-\ 3\\.\\ stromal\\ tumor\\ \\(leydig\\,\\ sertoli\\,\\ granulosa\\ cell\\,\\ mixed\\ undifferentiated\\ sex\\ cord\\)\ \(0\)\
\-\ 4\\.\\ mixed\\ germ\\ cell\\-stromal\\ \\(gonadoblastoma\\,\\ germ\\ cell\\-stromal\\-sex\\ cord\\)\ \(0\)\
\-\ 5\\.\\ metastatic\\ \\(lymphoma\\,\\ leukemia\\,\\ myeloma\\,\\ carcinoma\\)\ \(0\)\
\-\ 6\\.\\ other\\ rare\\ tumors\\ and\\ tumorous\\ conditions\\.\ \(0\)\
\-\ ddx\\:\\ testicular\\ calcifications\ \(0\)\
\-\ 1\\.\\ solitary\\,\\ postinflammatory\\ granulomatous\\,\\ vascular\\.\ \(0\)\
\-\ 2\\.\\ microlithiasis\ \(0\)\
\-\ 3\\.\\ \\"burned\\-out\\"\\ germ\\ cell\\ tumor\ \(0\)\
\-\ 4\\.\\ large\\ cell\\ calcifying\\ sertoli\\ cell\\ tumor\ \(0\)\
\-\ 5\\.\\ teratoma\ \(0\)\
\-\ 6\\.\\ mixed\\ germ\\ cell\\ tumor\ \(0\)\
\-\ 7\\.\\ sarcoid\ \(0\)\
\-\ 8\\.\\ tuberculosis\ \(0\)\
\-\ 9\\.\\ chronic\\ infarct\ \(0\)\
\-\ ddx\\ from\\ rumack\\,\\ diagnostic\\ ultrasound\\,\\ 3rd\\ ed\\.\ \(0\)\
\-\ 19yo\\ male\\ with\\ 8\\ month\\ history\\ of\\ slowly\\ enlarging\\ left\\ testicular\\ mass\\.\ \(1\)\
\-\ due\\ to\\ what\\ appeared\\ at\\ presentation\\ to\\ be\\ a\\ rather\\ advanced\\ tumor\\ state\\,\\ along\\ with\\ bilateral\\,\\ numerous\\,\\ large\\ microliths\\,\\ there\\ was\\ brief\\ discussion\\ as\\ to\\ if\\ both\\ testicles\\ should\\ be\\ removed\\ concurrently\\ due\\ to\\ risk\\ of\\ cancer\\ in\\ the\\ contralateral\\ testicle\\.\ \(0\)\
\-\ although\\,\\ the\\ general\\ impression\\ derived\\ from\\ the\\ literature\\ indicates\\ testicular\\ microlithiasis\\ increases\\ ones\\ chance\\ of\\ having\\ testicular\\ cancer\\,\\ there\\ is\\ no\\ good\\ data\\ as\\ to\\ the\\ actual\\ risk\\.\\ \\ there\\ is\\ also\\ little\\ prospective\\ data\\ on\\ the\\ risk\\ of\\ developing\\ a\\ future\\ cancer\\.\\ \\ given\\ the\\ lack\\ of\\ clear\\ risk\\,\\ the\\ complications\\ of\\ complete\\ surgical\\ castration\\,\\ and\\ the\\ very\\ high\\ cure\\ rates\\ for\\ testicular\\ cancers\\,\\ surgery\\ solely\\ to\\ the\\ affected\\ testicle\\ coupled\\ with\\ follow\\ up\\ was\\ deemed\\ to\\ be\\ sufficient\\.\ \(0\)\
\-\ in\\ an\\ otherwise\\ healthy\\ patient\\ with\\ microlithiasis\\,\\ the\\ most\\ common\\ follow\\ up\\ is\\ yearly\\ sonography\\.\\ \\ again\\,\\ given\\ the\\ uncertain\\ risk\\,\\ the\\ relatively\\ common\\ incidence\\ of\\ microlithiasis\\,\\ the\\ high\\ cure\\ rates\\ for\\ testicular\\ tumors\\,\\ and\\ the\\ possible\\ deleterious\\ psychologic\\ and\\ economic\\ burdens\\ of\\ patients\\ recieving\\ yearly\\ cancer\\ screening\\ sonography\\,\\ some\\ authors\\ recommend\\ yearly\\ physical\\ examination\\ and\\ routine\\ self\\ examination\\ only\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ microlithiasis\\:\\ 0\\.32296926680975674\ \(0\)\
\-\ testicular\\:\\ 0\\.2862066214158374\ \(0\)\
\-\ testicle\\:\\ 0\\.2631291903950391\ \(0\)\
\-\ cell\\:\\ 0\\.24939381008616143\ \(0\)\
\-\ germ\\:\\ 0\\.24427772847394846\ \(0\)\
\-\ yearly\\:\\ 0\\.20557744508784137\ \(0\)\
\-\ tumor\\:\\ 0\\.1596256089525278\ \(0\)\
\-\ risk\\:\\ 0\\.15575363380649368\ \(0\)\
\-\ mixed\\:\\ 0\\.14435297822875656\ \(0\)\
\-\ stromal\\:\\ 0\\.14289151733076988\ \(0\)\
\-\ sonography\\:\\ 0\\.1388176196186159\ \(0\)\
\-\ ddx\\:\\ 0\\.12429840125666138\ \(0\)\
\-\ the\\:\\ 0\\.12178799207704702\ \(0\)\
\-\ cancer\\:\\ 0\\.11615421864578791\ \(0\)\
\-\ sertoli\\:\\ 0\\.11083027762242942\ \(0\)\
\-\ cure\\:\\ 0\\.11083027762242942\ \(0\)\
\-\ sex\\:\\ 0\\.10502961854048401\ \(0\)\
\-\ seminoma\\:\\ 0\\.0956916153015567\ \(0\)\
\-\ rates\\:\\ 0\\.0908636696218505\ \(0\)\
\-\ large\\:\\ 0\\.0873766535537991\ \(0\)\
\-\ to\\:\\ 0\\.08719292468069231\ \(0\)\
\-\ data\\:\\ 0\\.0855396547506865\ \(0\)\
\-\ of\\:\\ 0\\.07678531573369801\ \(0\)\
\-\ teratoma\\:\\ 0\\.07540092260582004\ \(0\)\
\-\ removed\\:\\ 0\\.07407091697378211\ \(0\)\
\-\ spermatocytic\\:\\ 0\\.0697207820700078\ \(0\)\
\-\ tumorous\\:\\ 0\\.0697207820700078\ \(0\)\
\-\ psychologic\\:\\ 0\\.0697207820700078\ \(0\)\
\-\ burdens\\:\\ 0\\.0697207820700078\ \(0\)\
\-\ recieving\\:\\ 0\\.0697207820700078\ \(0\)\
\-\ gonadoblastoma\\:\\ 0\\.06662192939098972\ \(0\)\
\-\ 19yo\\:\\ 0\\.06662192939098972\ \(0\)\
\-\ castration\\:\\ 0\\.06662192939098972\ \(0\)\
\-\ deleterious\\:\\ 0\\.06662192939098972\ \(0\)\
\-\ mass\\:\\ 0\\.06661126256431063\ \(0\)\
\-\ classic\\:\\ 0\\.06521664074509571\ \(0\)\
\-\ cord\\:\\ 0\\.06463315684324777\ \(0\)\
\-\ 352\\:\\ 0\\.06442325842499168\ \(0\)\
\-\ developement\\:\\ 0\\.06442325842499168\ \(0\)\
\-\ microliths\\:\\ 0\\.06442325842499168\ \(0\)\
\-\ economic\\:\\ 0\\.06442325842499168\ \(0\)\
\-\ tumors\\:\\ 0\\.0641264113581002\ \(0\)\
\-\ postinflammatory\\:\\ 0\\.06271783673033089\ \(0\)\
\-\ nonseminomatous\\:\\ 0\\.0613244057459736\ \(0\)\
\-\ concurrently\\:\\ 0\\.06014627663547138\ \(0\)\
\-\ given\\:\\ 0\\.05998034229841529\ \(0\)\
\-\ left\\:\\ 0\\.05948728397685925\ \(0\)\
\-\ granulosa\\:\\ 0\\.05912573477997557\ \(0\)\
\-\ calcifying\\:\\ 0\\.05912573477997557\ \(0\)\
\-\ rumack\\:\\ 0\\.05912573477997557\ \(0\)\
\-\ deemed\\:\\ 0\\.05822555306695552\ \(0\)\
\-\ solely\\:\\ 0\\.05742031308531478\ \(0\)\
\-\ ones\\:\\ 0\\.05669188491697646\ \(0\)\
\-\ leydig\\:\\ 0\\.056026882100957485\ \(0\)\
\-\ examination\\:\\ 0\\.05579559659158143\ \(0\)\
\-\ rx\\:\\ 0\\.05541513881121471\ \(0\)\
\-\ undifferentiated\\:\\ 0\\.05541513881121471\ \(0\)\
\-\ coupled\\:\\ 0\\.05541513881121471\ \(0\)\
\-\ choriocarcinoma\\:\\ 0\\.05432146040629669\ \(0\)\
\-\ actual\\:\\ 0\\.05432146040629669\ \(0\)\
\-\ in\\:\\ 0\\.05422735080374794\ \(0\)\
\-\ intratesticular\\:\\ 0\\.053828211134959454\ \(0\)\
\-\ bhcg\\:\\ 0\\.05336487466537549\ \(0\)\
\-\ derived\\:\\ 0\\.05336487466537549\ \(0\)\
\-\ be\\:\\ 0\\.05305644251461103\ \(0\)\
\-\ carcinoma\\:\\ 0\\.052155276332440714\ \(0\)\
\-\ brief\\:\\ 0\\.052122789440298654\ \(0\)\
\-\ testicles\\:\\ 0\\.052122789440298654\ \(0\)\
\-\ there\\:\\ 0\\.05204110009212667\ \(0\)\
\-\ embryonal\\:\\ 0\\.05105462929311654\ \(0\)\
\-\ authors\\:\\ 0\\.05105462929311654\ \(0\)\
\-\ expect\\:\\ 0\\.05072935845594137\ \(0\)\
\-\ recommend\\:\\ 0\\.05072935845594137\ \(0\)\
\-\ prospective\\:\\ 0\\.05041736774563786\ \(0\)\
\-\ due\\:\\ 0\\.05012052067874639\ \(0\)\
\-\ yolk\\:\\ 0\\.05011761516619859\ \(0\)\
\-\ chance\\:\\ 0\\.05011761516619859\ \(0\)\
\-\ cm\\:\\ 0\\.050076279194363735\ \(0\)\
\-\ high\\:\\ 0\\.04955513477997923\ \(0\)\
\-\ common\\:\\ 0\\.049448763980611106\ \(0\)\
\-\ predominately\\:\\ 0\\.049283036526296675\ \(0\)\
\-\ uncertain\\:\\ 0\\.04853068748994333\ \(0\)\
\-\ sufficient\\:\\ 0\\.04806735102035937\ \(0\)\
\-\ ldh\\:\\ 0\\.04742110333299577\ \(0\)\
\-\ physical\\:\\ 0\\.04727837683355972\ \(0\)\
\-\ follow\\:\\ 0\\.04700492728366839\ \(0\)\
\-\ bilateral\\:\\ 0\\.04686106342467188\ \(0\)\
\-\ cancers\\:\\ 0\\.04682526579528254\ \(0\)\
\-\ afp\\:\\ 0\\.045925084082262486\ \(0\)\
\-\ coarse\\:\\ 0\\.045925084082262486\ \(0\)\
\-\ indicates\\:\\ 0\\.045925084082262486\ \(0\)\
\-\ increases\\:\\ 0\\.04575710564810042\ \(0\)\
\-\ was\\:\\ 0\\.0455817543975541\ \(0\)\
\-\ myeloma\\:\\ 0\\.04527424755591885\ \(0\)\
\-\ and\\:\\ 0\\.04504372988321561\ \(0\)\
\-\ self\\:\\ 0\\.04482009152118247\ \(0\)\
\-\ monitor\\:\\ 0\\.0445316530979052\ \(0\)\
\-\ lobular\\:\\ 0\\.04425370570042303\ \(0\)\
\-\ state\\:\\ 0\\.04398551288128056\ \(0\)\
\-\ future\\:\\ 0\\.043726413116264455\ \(0\)\
\-\ contralateral\\:\\ 0\\.0436000844369046\ \(0\)\
\-\ up\\:\\ 0\\.04313139318196312\ \(0\)\
\-\ hard\\:\\ 0\\.04311466982652168\ \(0\)\
\-\ appeared\\:\\ 0\\.04311466982652168\ \(0\)\
\-\ slowly\\:\\ 0\\.04299798494792614\ \(0\)\
\-\ little\\:\\ 0\\.04288305479579719\ \(0\)\
\-\ literature\\:\\ 0\\.04254828400576224\ \(0\)\
\-\ impression\\:\\ 0\\.042439874938578113\ \(0\)\
\-\ what\\:\\ 0\\.041919761980209774\ \(0\)\
\-\ developing\\:\\ 0\\.041721238842164395\ \(0\)\
\-\ advanced\\:\\ 0\\.040975016227855855\ \(0\)\
\-\ sarcoid\\:\\ 0\\.04088666020226248\ \(0\)\
\-\ enlarging\\:\\ 0\\.04071295474565808\ \(0\)\
\-\ solitary\\:\\ 0\\.03989913226890806\ \(0\)\
\-\ leukemia\\:\\ 0\\.03982232045560563\ \(0\)\
\-\ conditions\\:\\ 0\\.03982232045560563\ \(0\)\
\-\ 3rd\\:\\ 0\\.03982232045560563\ \(0\)\
\-\ for\\:\\ 0\\.039641570911252894\ \(0\)\
\-\ again\\:\\ 0\\.03888824639838798\ \(0\)\
\-\ sac\\:\\ 0\\.03882090930119169\ \(0\)\
\-\ granulomatous\\:\\ 0\\.03875416030842351\ \(0\)\
\-\ rather\\:\\ 0\\.03862238616314631\ \(0\)\
\-\ tuberculosis\\:\\ 0\\.038365464118929\ \(0\)\
\-\ discussion\\:\\ 0\\.03817828632866561\ \(0\)\
\-\ having\\:\\ 0\\.03758553115078108\ \(0\)\
\-\ incidence\\:\\ 0\\.037528707758228294\ \(0\)\
\-\ lack\\:\\ 0\\.03730554705479473\ \(0\)\
\-\ hypoechoic\\:\\ 0\\.03725076036074612\ \(0\)\
\-\ healthy\\:\\ 0\\.03698256754160365\ \(0\)\
\-\ numerous\\:\\ 0\\.03682605604296353\ \(0\)\
\-\ infarct\\:\\ 0\\.0362781353461697\ \(0\)\
\-\ pending\\:\\ 0\\.03585732937638883\ \(0\)\
\-\ affected\\:\\ 0\\.03585732937638883\ \(0\)\
\-\ is\\:\\ 0\\.03581784364778473\ \(0\)\
\-\ normal\\:\\ 0\\.03560056621548778\ \(0\)\
\-\ relatively\\:\\ 0\\.03550179033691199\ \(0\)\
\-\ good\\:\\ 0\\.03545848874180565\ \(0\)\
\-\ screening\\:\\ 0\\.035415431100641964\ \(0\)\
\-\ as\\:\\ 0\\.035028767582329895\ \(0\)\
\-\ general\\:\\ 0\\.03499769264488648\ \(0\)\
\-\ ed\\:\\ 0\\.03487669733007777\ \(0\)\
\-\ from\\:\\ 0\\.03462960517895551\ \(0\)\
\-\ with\\:\\ 0\\.034147197751800876\ \(0\)\
\-\ routine\\:\\ 0\\.03376170776156627\ \(0\)\
\-\ irregular\\:\\ 0\\.0336586584103908\ \(0\)\
\-\ complications\\:\\ 0\\.03339046559124833\ \(0\)\
\-\ diagnostic\\:\\ 0\\.03322750182452413\ \(0\)\
\-\ rare\\:\\ 0\\.03291164236643279\ \(0\)\
\-\ calcifications\\:\\ 0\\.031817963961514775\ \(0\)\
\-\ clear\\:\\ 0\\.03160638751356416\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.031554396081146824\ \(0\)\
\-\ very\\:\\ 0\\.03127459837229097\ \(0\)\
\-\ malignant\\:\\ 0\\.03107735617132923\ \(0\)\
\-\ otherwise\\:\\ 0\\.03107735617132923\ \(0\)\
\-\ complete\\:\\ 0\\.030559805731372715\ \(0\)\
\-\ labs\\:\\ 0\\.03020426669189587\ \(0\)\
\-\ presentation\\:\\ 0\\.030011312825460094\ \(0\)\
\-\ elevated\\:\\ 0\\.029720522436910635\ \(0\)\
\-\ although\\:\\ 0\\.02967986962248747\ \(0\)\
\-\ possible\\:\\ 0\\.0295392638758769\ \(0\)\
\-\ type\\:\\ 0\\.02924640386665527\ \(0\)\
\-\ along\\:\\ 0\\.029208190231585114\ \(0\)\
\-\ radiation\\:\\ 0\\.028890864827178425\ \(0\)\
\-\ vascular\\:\\ 0\\.028781940735155553\ \(0\)\
\-\ should\\:\\ 0\\.02844691244571552\ \(0\)\
\-\ some\\:\\ 0\\.02743068485005296\ \(0\)\
\-\ only\\:\\ 0\\.027236810563179906\ \(0\)\
\-\ ultrasound\\:\\ 0\\.026891318470189565\ \(0\)\
\-\ month\\:\\ 0\\.02652044031649866\ \(0\)\
\-\ lymphoma\\:\\ 0\\.025964596828843296\ \(0\)\
\-\ chronic\\:\\ 0\\.025877817343972577\ \(0\)\
\-\ if\\:\\ 0\\.02533082703991125\ \(0\)\
\-\ patients\\:\\ 0\\.024525587058270504\ \(0\)\
\-\ both\\:\\ 0\\.024311719761818364\ \(0\)\
\-\ metastatic\\:\\ 0\\.023910666586568995\ \(0\)\
\-\ surgery\\:\\ 0\\.023439486266484687\ \(0\)\
\-\ most\\:\\ 0\\.022689097438171456\ \(0\)\
\-\ other\\:\\ 0\\.022640520721089345\ \(0\)\
\-\ surgical\\:\\ 0\\.021189469304787413\ \(0\)\
\-\ lesion\\:\\ 0\\.020901278102428884\ \(0\)\
\-\ also\\:\\ 0\\.02050668756573689\ \(0\)\
\-\ male\\:\\ 0\\.019410974631034025\ \(0\)\
\-\ an\\:\\ 0\\.01667127184683902\ \(0\)\
\-\ history\\:\\ 0\\.01665650331839488\ \(0\)\
\-\ at\\:\\ 0\\.016467065127739218\ \(0\)\
\-\ right\\:\\ 0\\.014454144675079623\ \(0\)\
\-\ patient\\:\\ 0\\.014179852021350546\ \(0\)\
\-\ no\\:\\ 0\\.014177184873847766\ \(0\)\
\-\ on\\:\\ 0\\.013166983403730362\ \(0\)\
